|
|||||
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions 
Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties. . . . → Read More: Faster Crop Breeding Techniques Made Available to Other Scientists 
New data from a continuing survey of smoking among school-age children shows large increases in electronic cigarette use in high school and middle school children in just the past year. . . . → Read More: Survey Shows Sharp Rise in Teen E-Cigarette Use 
Our friends at Statista posted a chart showing the median number of deaths by country in Europe from microbes resistant to antibiotics, this weekend’s infographic. . . . → Read More: Infographic – Superbugs Annually Kill 33,000 in Europe 
The Food and Drug Administration says it’s streamlining policies for making drugs and medical devices in clinical trials or under review available for people in the U.S. with life-threatening conditions. . . . → Read More: FDA Updating Expanded Access to Investigational Drugs, Devices 
The Food and Drug Administration cleared a consumer genetics company’s tests for gene variations associated with effective or adverse drug reactions, but warned about similar tests from non-authorized providers. . . . → Read More: FDA Clears Some Drug Reaction Genetic Tests, Warns About Others  One comment - (Comments are closed)  New products, Regulations  biomedical, engineering, FDA, genomics, life sciences, medical device, pharmaceuticals 
The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants. . . . → Read More: FDA Preparing Animal, Plant Biotech Regulatory Guidance 2 comments - (Comments are closed) Regulations agriculture, biotechnology, FDA, genomics, life sciences, pharmaceuticals 
National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle. . . . → Read More: NIH Stops Stem Cell Heart Failure Trial Over Retracted Data One comment - (Comments are closed) Regulations biomedical, biotechnology, clinical trials, heart disease, life sciences, NIH, pharmaceuticals, preclinical, stem cells, university 
Our friends at Statista reported on a study by the Internet Crime Complaint Center or IC3 that tracks cyber crimes in the U.S., our infographic for this weekend. . . . → Read More: Infographic – Top U.S. Cyber Crimes 
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years. . . . → Read More: Diabetes Drug Assessed Long-Term Against All Other Treatments Comments are closed Regulations biomedical, clinical trials, FDA, life sciences, pharmaceuticals, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
